Follow
Krishna S. Tummala
Krishna S. Tummala
Post doctoral fellow, Massachusetts General Hospital; Harvard Medical School
Verified email at mgh.harvard.edu - Homepage
Title
Cited by
Cited by
Year
Metabolic inflammation-associated IL-17A causes non-alcoholic steatohepatitis and hepatocellular carcinoma
AL Gomes, A Teijeiro, S Burén, KS Tummala, M Yilmaz, A Waisman, ...
Cancer cell 30 (1), 161-175, 2016
3312016
Inhibition of de novo NAD+ synthesis by oncogenic URI causes liver tumorigenesis through DNA damage
KS Tummala, AL Gomes, M Yilmaz, O Graña, L Bakiri, I Ruppen, ...
Cancer cell 26 (6), 826-839, 2014
1962014
Hepatocellular Carcinomas Originate Predominantly from Hepatocytes and Benign Lesions from Hepatic Progenitor Cells
KST Marta Brandt, Ana Teijeiro, Osvaldo Grana, Robert F. Schwabe, Cristian ...
Cell Reports 19, 584-600, 2017
1292017
Regulation of OGT by URI in response to glucose confers c-MYC-dependent survival mechanisms
S Burén, AL Gomes, A Teijeiro, MA Fawal, M Yilmaz, KS Tummala, ...
Cancer cell 30 (2), 290-307, 2016
852016
Mutant IDH inhibits IFNγ–TET2 signaling to promote immunoevasion and tumor maintenance in cholangiocarcinoma
MJ Wu, L Shi, J Dubrot, J Merritt, V Vijay, TY Wei, E Kessler, KE Olander, ...
Cancer discovery 12 (3), 812-835, 2022
552022
mTORC1 inactivation promotes colitis-induced colorectal cancer but protects from APC loss-dependent tumorigenesis
M Brandt, TP Grazioso, MA Fawal, KS Tummala, R Torres-Ruiz, ...
Cell Metabolism 27 (1), 118-135. e8, 2018
442018
ISL2 is a putative tumor suppressor whose epigenetic silencing reprograms the metabolism of pancreatic cancer
H Ozturk, H Cingoz, T Tufan, J Yang, SJ Adair, KS Tummala, C Kuscu, ...
Developmental Cell 57 (11), 1331-1346. e9, 2022
132022
NRF2: translating the redox code
KS Tummala, F Kottakis, N Bardeesy
Trends in molecular medicine 22 (10), 829-831, 2016
92016
Oncogene-induced NAD+ depletion in tumorigenesis
KS Tummala, N Djouder
Oncoscience 2 (4), 318, 2015
52015
ISL2 is an epigenetically silenced tumor suppressor and regulator of metabolism in pancreatic cancer
T Tufan, J Yang, KS Tummala, H Cingoz, C Kuscu, SJ Adair, G Comertpay, ...
bioRxiv, 2020.05. 23.112839, 2020
12020
Methods for Treating Cancer
N Djouder, KS Tummala
US Patent App. 15/500,199, 2017
12017
[14C]-Tryptophan Metabolic Tracing in Liver Cancer Cells
KS Tummala, N Djouder
bio-protocol 5 (17), 2015
12015
AGENTS FOR USE IN TREATING LIVER AND PANCREATIC CANCER
KST Nabil Djouder
EP Patent WO 2016/016391 A1, 2016
2016
URI GENERATES METABOLIC ALTERATIONS-DEPENDENT DNA DAMAGE INDUCING HETEROGENEOUS LIVER TUMOURS
KS Tummala, AL Gomes, IM Ruppen, L Bakiri, RC Olivas, O Graña, ...
Journal of Hepatology 58, S447-S448, 2013
2013
URI HEPATOCYTE-SPECIFIC OVEREXPRESSION IS SUFFICIENT TO INDUCE NON ALCOHOLIC STEATOHEPATITIS (NASH)
A Gomes, K Tummala, N Djouder
Journal of Hepatology 58, S510, 2013
2013
The system can't perform the operation now. Try again later.
Articles 1–15